Mr. Darren Alkins CEO at SPL – Scientific Protein Laboratories, speaks with IPI about their continued development in their science and technical expertise to meet th...

Over the past couple of years, how we live our lives and do business have both fundamentally and irrevocably shifted. Richard Ettl at SkyCell explains that despite t...

The global drug-device combination products market was estimated to be worth US$ 123.5 billion in 2020 and is forecast to grow at a CAGR of 8.2% between now and 2027...

The healthcare systems in Southeast Asia are at a critical juncture today. The new wave of COVID-19 infections is straining healthcare facilities as cases continue t...

A company’s attitude towards risk fundamentally affects their product development strategy, which can vary between the development of a simple or prototype formulati...

Neurological disorders are incredibly complex, and this is reflected in the lack of knowledge of the underlying pathological mechanism for many of these diseases, an...

The global pharmaceutical industry generated more than $1.25tr in revenue in 2019, up from $1.2tr in 2018, and the final figures for 2020 are expected to be even mor...

To reduce attrition rates in pharmaceutical research and development (R&D), powerful quantitative analytical methods are needed to monitor therapeutic compounds,...

Gene therapy is revolutionising the way we treat human diseases. Any technique that modifies a person’s genes to treat or cure a disease is considered a form of gene...

When you develop a new therapy, the device you develop or select to deliver will be a key to the overall success of your product. You may have spent considerable tim...